Prostate FA Plus with 5-Alpha-Reductase Blockers
On sale on the US market (according to the DSLD)
Patient One 1 MediNutritionals, food supplement from the US market
Prostate FA Plus with 5-Alpha-Reductase Blockers (Patient One 1 MediNutritionals), a food supplement au code-barres 853959004410, is described by its US market label. If sold in France, it would be subject to 6 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine E: up to 40 mg a day according to the label (at most 1 serving a day), above the maximum dose of 30 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Zinc: up to 30 mg a day according to the label (at most 1 serving a day), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Sélénium: up to 200 µg a day according to the label (at most 1 serving a day), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- À vérifier
Zinc: up to 30 mg a day according to the label, above the tolerable upper intake level from EFSAEuropean Food Safety Authority. for adults (25 mg a day). The EFSA reference covers total daily intake, from food and supplements.
Source: EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), limite supérieure de sécurité (UL).
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Prunus africana (Hook. f.) Kalkman: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Patient One 1 MediNutritionals
- Barcode
- 853959004410
- Form
- Capsule
- One serving
- 3 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Rice Bran Oil, Vegetable Cellulose, Chlorophyll
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Calories | Other | 12 Calorie(s) |
| Total Fat | Fat | 1.4 Gram(s) |
| Saturated Fat | Fat | 0.5 Gram(s) |
| Monounsaturated Fat | Fat | 0.5 Gram(s) |
| Polyunsaturated Fat | Fat | 0.4 Gram(s) |
| Vitamin E | Vitamin | 40 mg |
| Zinc | Mineral | 30 mg |
| Selenium | Mineral | 200 µg |
| Saw Palmetto extract (Serenoa repens) | Plant | 640 mg |
| Pumpkin Seed Oil | Fat | 150 mg |
| Phytosterols Complex | Fat | 400 mg |
| Lycopene | Other substance | 10 mg |
| Pygeum africanum 4:1 extract (Prunus africana) | Plant | 200 mg |
| Silica | Mineral | 6 mg |
| Bamboo extract (Bambusa vulgaris) | Plant | 5 mg |
| Stinging Nettles extract (Urtica dioica) | Plant | 1 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Prostate FA Plus with 5-Alpha-Reductase Blockers
Entered into DSLD on 23 August 2019. Withdrawn from the US market on 26 March 2021 (according to the DSLD).- Active ingredient removed : Bamboo extract (5 mg)
- Same quantity, different name: Phytosterols in this version; Phytosterols Complex on the displayed label (400 mg)
- Different quantity per serving : Silica: 5 mg in this version; 6 mg on the displayed label
Official label: Prostate FA Plus With 5-Alpha-Reduced Blockers
Entered into DSLD on 25 January 2017. Withdrawn from the US market on 28 February 2019 (according to the DSLD).- Active ingredient added : Calories from Fat (7 Calorie(s))
- Active ingredient added : Prostate Support Fatty Acid Blend (790 mg)
- Active ingredient removed : Bamboo extract (5 mg)
- Active ingredient removed : Stinging Nettles extract (1 mg)
- Same quantity, different name: Phytosterols in this version; Phytosterols Complex on the displayed label (400 mg)
- Different quantity per serving : Lycopene: 20 mg in this version; 10 mg on the displayed label
- Different unit, without conversion : Pumpkin seed oil: quantity not stated in this version; 150 mg on the displayed label
- Different unit, without conversion : Saw Palmetto extract: quantity not stated in this version; 640 mg on the displayed label
- Different unit, without conversion : Vitamin E: 60 IU in this version; 40 mg on the displayed label
Official label: Prostate FA Plus With 5-Alpha-Reduced Blockers
Entered into DSLD on 24 July 2015. Withdrawn from the US market on 20 September 2016 (according to the DSLD).- Active ingredient added : Calories from Fat (7 Calorie(s))
- Active ingredient added : Prostate Support Fatty Acid Blend (790 mg)
- Active ingredient added : Saw Palmetto (quantity not stated)
- Active ingredient removed : Bamboo extract (5 mg)
- Active ingredient removed : Saw Palmetto extract (640 mg)
- Active ingredient removed : Stinging Nettles extract (1 mg)
- Same quantity, different name: Phytosterols in this version; Phytosterols Complex on the displayed label (400 mg)
- Different quantity per serving : Lycopene: 20 mg in this version; 10 mg on the displayed label
- Different unit, without conversion : Pumpkin seed Oil: quantity not stated in this version; 150 mg on the displayed label
- Different unit, without conversion : Vitamin E: 60 IU in this version; 40 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Saw Palmetto extract
Read the warning, when it applies and the studies cited
SAW PALMETTO – SERENOA REPENS
Route of administration: Oral
Cautions and warnings
Condition of application: All subpopulations.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Adult males only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- USP-NF 2024: United States Pharmacopeia and the National Formulary. Rockville (MD): The United States Pharmacopeial Convention, Inc.; 2024.
Condition of application: Adult females only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).
Sources cited by Health Canada (1)
- UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1
Contraindications
Condition of application: Adult females only.
Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).
Sources cited by Health Canada (1)
- UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1
- Pygeum africanum 4:1 extract
Read the warning, when it applies and the studies cited
PYGEUM - PRUNUS AFRICANA
Route of administration: Oral
Cautions and warnings
Condition of application: Standardized extracts making a claim for symptoms of benign prostatic hyperplasia (adult males).
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (Goldman and Ausiello 2004).
Sources cited by Health Canada (1)
- Goldman L, Ausiello D. Cecil Textbook of Medicine. 22nd edition. Philadelphia (PA): Saunders; 2004.
Condition of application: Non-standardized preparations for adults (i.e., including women) (safety only).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
- Stinging Nettles extract
Read the warning, when it applies and the studies cited
STINGING NETTLE JUICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products except nutritive tonics.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Tilgner 1999).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Tilgner S. Herbal Medicine from the Heart of the Earth. Creswell (OR): Wise Acre Press; 1999.
Known adverse reactions
Condition of application: All products except those making only a diuretic claim*.
When using this product diuretic effect may occur.
*Note: This statement can be removed from the label if a diuretic claim is included.
Health Canada monograph dated 27 March 2026
STINGING NETTLE - URTICA DIOICA
Route of administration: Oral
Cautions and warnings
Condition of application: All products except nutritive tonics.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Tilgner 1999).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Tilgner S. Herbal Medicine from the Heart of the Earth. Creswell (OR): Wise Acre Press; 1999.
Known adverse reactions
All products except those making only a diuretic claim*
When using this product diuretic effect may occur.
*Note: This statement can be removed from the label if a diuretic claim is included.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Patient One 1 MediNutritionals
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Prostate FA Plus with 5-Alpha-Reductase Blockers (Patient One 1 MediNutritionals): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/853959004410-prostate-fa-plus-with-5-alpha-reductase-blockers-patient-one, updated 27 July 2021.